Accenture and Tokyo Women's Medical University to Conduct Joint Research on Potential Benefits of Artificial Intelligence for Kidney Transplant Treatment

TOKYO; Nov. 5, 2020 – Accenture (NYSE:ACN) and Tokyo Women’s Medical University (TWMU) have agreed to conduct joint research using artificial intelligence (AI) to verify and analyze kidney transplant test results, recognize early-stage kidney transplant rejection tendencies and to foresee side effects in efforts to identify more effective post-operation treatments for patients.

from News | Accenture Newsroom https://ift.tt/2TVeAvi




Comments

Popular posts from this blog

Add Custom Field in Output of Standard Report of ME2N

HANA Housekeeping using HANACleaner

Accenture to Strengthen Oracle Capabilities in the Middle East with AppsPro Acquisition